Grown Rogue International earnings release, May 12, 2026

Grown Rogue International Inc. (GRUSF) · Form 8-K, Item 2.02 · Filed · SEC filing

Grown Rogue Reports First

Quarter 2026 Results

Continued Solid New Jersey

Performance, Yield Improvements, Product Expansion, and New Market Progress Support Growth Plans & Upwardly Revised Revenue Guidance

MEDFORD, Ore., May 12, 2026 /CNW/ - Grown Rogue International

Inc. ("Grown Rogue," "we," "us," "our," or the "Company") (CSE: GRIN | OTC: GRUSF), a flower-forward cannabis company combining craft values with disciplined execution, today reported its unaudited financial results for the three months ended March 31, 2026. All currency is in U.S. dollars unless otherwise noted.

Results are presented in accordance with U.S. generally accepted accounting principles ("GAAP") and include consolidation of the Company's New Jersey operations, ABCO Garden State,

LLC ("ABCO"), within the Company's financial statements. Comparative periods have been recast, where applicable, in accordance with GAAP.

Highlights:

First Quarter 2026 Update

First quarter 2026 results reflected continued progress against the Company's growth plan, including increased contribution from New Jersey, continued operating discipline in Oregon and Michigan, and ongoing work to broaden the Company's product offering and market footprint. The quarter was also the first full quarter following the Company's transition to U.S. GAAP reporting and consolidation of ABCO, creating a clearer baseline for evaluating performance as expansion projects in New Jersey, Illinois, and Minnesota advance.

In New Jersey, demand and sell-through remained strong across packaged, branded products which represented 97% of New Jersey revenue in the quarter, Management believes quality, consistency, and affordability are the cornerstones of strong consumer loyalty across markets. The Company continued executing its Phase II expansion, which is expected to increase total New Jersey flowering canopy to approximately 16,000 square feet when complete later this year. As this capacity comes online, management anticipates short-term, modest reductions in the percentage of packaged, branded products sold.

In Oregon and Michigan, the Company continued to focus on controllable factors, including cost per pound, yields, harvest quality, product consistency, and targeted infrastructure improvements.

Oregon revenue increased approximately 4% year-over-year, while Michigan revenue increased approximately 10% year-over-year, primarily due to the pass-through of Michigan's new wholesale excise tax which was implemented on January 1, 2026. Excluding that impact, which was absorbed in price, Michigan revenue declined approximately 4% year-over-year. Both markets continued to experience pricing pressure, which impacted profitability in the quarter. In Michigan, yield performance continued to improve, and the Company is beginning to apply similar infrastructure improvements in Oregon with the objective of moving flower yield performance from recent levels in the 70 g/sf range toward the 80 g/sf range.

The new vape category also reflects a product expansion strategy focused on staying true to our flower-forward ethos with disciplined SKU expansion and fuller utilization of the Company's efficient production capabilities. In Oregon, the Company is using its cultivation capabilities to convert select biomass streams that historically carry lower margins, into higher value branded vape products. Management views this as a capital-efficient way to extend the Grown Rogue brand into new consumption formats while preserving the genetics, flavor, and quality standards associated with its flower.

The Company also advanced its new-market pipeline, including construction activity in Minnesota and progressing towards restarting the recently inhabited turn-key Illinois facility. These projects are expected to be important contributors to the Company's 2027 financial performance, subject to the assumptions and risks described in this release.

Management Commentary

"The first quarter was a continuation of the plan we laid out earlier this year: keep building in markets where we believe quality flower and disciplined execution can earn attractive returns, while staying sharp in mature markets that require strong cost control and operational excellence," said Obie Strickler,

Chief Executive Officer. "New Jersey continues to validate our thesis, with consistent demand for our packaged, branded products and meaningful expansion work underway. At the same time, we are seeing evidence that the technology upgrade work done in Michigan is translating into stronger yield performance, and we have begun upgrading our facilities in Oregon. Mature markets keep us focused on the fundamentals that have always mattered most to Grown Rogue: genetics, passion, quality, consistency, and efficient production.

In addition to the markets themselves being cash flow contributors, they provide a best-practices laboratory for us to adapt practices across markets as the teams and facilities are ready."

Mr. Strickler continued, "Our priorities for

2026 remain clear. We are focused on completing Phase II in New Jersey, advancing our Minnesota buildout, preparing Illinois for operations, and continuing to broaden our product offering without losing the discipline that defines our approach. The new vape category is an example of that approach: using more of the plant and our in-house capabilities to create higher-value branded products in formats consumers are already choosing, while staying true to being flower forward with the genetics, flavor and flower integrity that define Grown Rogue. Assuming we navigate the regulatory timelines and inherent execution risks, we believe these initiatives can position Grown Rogue to enter 2027 with a more diversified operating base, a larger share of revenue from newer markets, and a stronger platform for sustainable profit growth."

Josh Rosen, Chief Strategy Officer, added, "Our... (truncated)market. It is based on disciplined underwriting and building where we believe our capabilities matter most. Minnesota is a new-build opportunity in a market we believe can support attractive economics, while

Illinois is a lower-capital-intensity, 'fixer-upper' opportunity where operational discipline may unlock meaningful value. Across the portfolio, our focus remains on improving yields, quality, and consistency, while expanding wallet share with a targeted set of flower-forward products.

Andrew Marchington, Chief Financial Officer, commented,

"First quarter 2026 marks our first quarterly reporting period following the transition to U.S. GAAP reporting and the consolidation of ABCO within our financial statements. We remain focused on transparent reporting, working capital discipline, cost controls, and allocating capital to projects that we believe meet our return thresholds. As we move through 2026 into 2027, we expect investors will have a clearer view of the operating profile of the business and the contribution of our newer markets. Of note, as we've managed our transition to GAAP, we've also been working on the integration of our core operational data with our financial performance and we found that we had not properly eliminated all of our selling costs as we recalibrated our cost of production metrics in our Operating KPIs, thus leading to a restatement of that metric looking backward as well."

Selected First Quarter 2026 Financial Results (Unaudited)

Selected Quarterly Revenue by Segment (Unaudited)

Operating KPIs by Market

Guidance and Long-Term (3-5 Year) Growth Objectives

Financial statements

Income Statement

(US$ in millions)

2026 – $2025 – $
RevenueProduct sales9,155,6587,150,183
RevenueTotal revenue9,155,6587,150,183
Cost of goods soldCost of finished cannabis inventory sold-5,198,024-3,786,436
Cost of goods soldTotal cost of goods sold-5,198,024-3,786,436
Cost of goods soldGross profit3,957,6343,363,747
Operating expensesAmortization (Notes 9, 10)91,162104,984
Operating expensesGeneral and administrative3,611,8232,532,254
Operating expensesShare-based compensation (Note 16)154,9941,435,910
Operating expensesTotal operating expenses3,857,9794,073,148
Operating expensesIncome (loss) from operations99,655-709,401
Other income (expense)Interest and accretion expense (Note 11, 13)-549,980-258,171
Other income (expense)165,268796,956
Other income (expense)Interest income (Note 8)42,18735,937
Other income (expense)Unrealized gain on derivative liability (Note 13)66,3772,864,373
Other income (expense)Realized loss on derivative liability (Note 13)-29,288
Other income (expense)Unrealized gain (loss) on warrant asset (Note 6)-2,191,084-1,172,492
Other income (expense)Unrealized gain on change in fair value of warrant liability (Note 13.3)770,714
Other income (expense)Loss on equity investment in associate (Note 7)-99,657-153,734
Other income (expense)Total other income (expense), net-1,796,1752,083,581
Other income (expense)Income (loss) before income tax expense-1,696,5201,374,180
Other income (expense)Income tax expense (Note 18)-516,871-631,310
Other income (expense)Net income (loss)-2,213,391742,870
Other comprehensive incomeCurrency translation adjustment7,832
Other comprehensive incomeTotal comprehensive income (loss)-2,213,391750,702
Other comprehensive incomeBasic income (loss) per share00
Other comprehensive incomeBasic weighted average number of subordinate voting common shares outstanding249,914,536227,189,980
Other comprehensive incomeDiluted income (loss) per share00
Other comprehensive incomeDiluted weighted average number of subordinate voting common shares outstanding249,914,536231,795,875
Net income (loss) for the period attributable to:Shareholders-2,702,217598,782
Net income (loss) for the period attributable to:Non-controlling interest488,826144,088
Net income (loss) for the period attributable to:Net income (loss)-2,213,391742,870
Total comprehensive income (loss) for the period attributable to:Shareholders-2,702,217606,614
Total comprehensive income (loss) for the period attributable to:Non-controlling interest488,826144,088
Total comprehensive income (loss) for the period attributable to:Total comprehensive income (loss)-2,213,391750,702

Income Statement

Adjusted EBITDA Reconciliation — (US$ in millions)

20262025
Net income (loss)-2,213,391742,870
Add back amortization of property and equipment included in cost of sales822,531434,202
Add back interest and interest accretion expense549,980258,171
Add back amortization of property and equipment91,162104,984
Add back loss on equity investment in associate99,657153,734
Add back income tax expense516,871631,310
Deduct gain on derivative liability-66,377-2,835,085
Deduct interest expense and other income (expense)-207,455-832,893
Add back changes in FV on warrants asset and liability1,420,3701,172,492
EBITDA1,013,346-170,215
Add back share-based compensation154,9941,435,910
Deduct GAAP bad debt conversion adjustment-79,000
Add back pre-operational startup costs ¹396,165
Adjusted EBITDA1,564,5051,186,695

Income Statement

Consolidated — (US$ in millions)

Oregon – $Michigan – $New Jersey – $Corporate – $Consolidated – $
Revenue2,996,7642,743,5273,415,3689,155,658
Total cost of goods sold-2,445,600-1,418,264-1,334,160-5,198,024
Gross profit551,1641,325,2622,081,2083,957,634
Operating expensesGeneral and administration445,276995,421867,2421,303,8843,611,823
Operating expensesDepreciation and amortization31,34137,91520,5301,37691,162
Operating expensesShare based compensation154,994154,994
Other income and expenseInterest and accretion-5,477-4,013-141,003-399,487-549,980
Other income and expenseInterest and other income (expense)10,00061,664-7,610143,401207,455
Other income and expenseUnrealized loss on derivative liability66,37766,377
Other income and expenseUnrealized gain (loss) on warrants asset-2,191,084-2,191,084
Other income and expenseUnrealized gain on warrant liability770,714770,714
Other income and expenseLoss on equity method investment-99,657-99,657
Other income and expenseNet income (loss) before tax79,070349,5781,044,823-3,169,990-1,696,520
Other income and expenseTax-516,871-516,871
Other income and expenseNet income (loss)79,070349,5781,044,823-3,686,861-2,213,391
EBITDA AdjustmentsAmortization in cost of sales320,567207,260294,703822,531
EBITDA AdjustmentsAmortization of property and equipment31,34137,91520,5301,37691,162
EBITDA AdjustmentsInterest and accretion5,4774,013141,003399,487549,980
EBITDA AdjustmentsInterest and other income (expense)-10,000-61,6647,610-143,401-207,455
EBITDA AdjustmentsChange in fair value of derivative liability-66,377-66,377
EBITDA AdjustmentsUnrealized warrants asset1,420,3701,420,370
EBITDA AdjustmentsLoss on equity method investment99,65799,657

Income Statement

Adjusted EBITDA Reconciliation — (US$ in millions)

Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025
Revenue9,155,6588,753,4988,514,2688,009,9877,150,183
Total cost of goods sold-5,198,024-5,184,072-4,855,244-4,455,502-3,786,436
Gross profit3,957,6343,569,4263,659,0243,554,4853,363,747
Operating expensesGeneral and administration3,611,8233,468,8222,964,4692,678,3722,532,254
Operating expensesDepreciation and amortization91,162378,654110,693107,927104,984
Operating expensesShare based compensation154,994306,308314,951336,8251,435,910
Other income and expensesInterest and accretion-549,980-283,105-410,925-432,553-258,171
Other income and expensesInterest and other income (expense)207,455260,679156,439-137,550832,893
Other income and expensesUnrealized loss on derivative liability66,37796,813-24,242-2,892,0272,864,373
Other income and expensesRealized gain on derivative liability0005,889,032-29,288
Other income and expensesUnrealized gain (loss) on warrants asset-2,191,084-573,9562,162,087-168,162-1,172,492
Other income and expensesUnrealized gain on warrant liability770,7140000
Other income and expensesLoss on equity method investment-99,657-108,809-75,733-114,686-153,734
Other income and expensesNet income (loss) before tax-1,696,520-1,192,7362,076,5372,575,4151,374,180
Other income and expensesTax-516,871459,289-511,381-920,037-631,310
Other income and expensesNet income (loss)-2,213,391-733,4471,565,1561,655,378742,870
EBITDA adjustmentsAmortization in cost of sales822,531702,751895,472658,232434,202
EBITDA adjustmentsAmortization of property and equipment91,162378,654110,693107,927104,984
EBITDA adjustmentsInterest and accretion549,980283,105410,925432,553258,171
EBITDA adjustmentsInterest and other income (expense)-207,455-260,679-156,439137,550-832,893
EBITDA adjustmentsChange in fair value of derivative liability-66,377-96,81324,242-2,997,005-2,835,085
EBITDA adjustmentsUnrealized warrants asset1,420,370573,956-2,162,087168,1621,172,492
EBITDA adjustmentsLoss on equity method investment99,657108,80975,733114,686153,734
EBITDA adjustmentsIncome tax516,871-459,289511,381920,037631,310
EBITDA adjustmentsEBITDA before one-time adjustments1,013,346497,0471,275,0761,197,520-170,215
EBITDA adjustmentsShare-based compensation154,994306,308314,951336,8251,435,910
EBITDA adjustmentsGolden Harvests acquisition costs060,000060,0000
EBITDA adjustmentsGAAP conversion bad debt adjustment0237,000-79,000-79,000-79,000
EBITDA adjustmentsPre-operational startup costs396,16572,217000
EBITDA adjustmentsAdjusted EBITDA1,564,5051,172,5721,511,0271,515,3451,186,695

Balance Sheet

March 31, 2026 — (US$ in millions)

March 31, 2026 – $December 31, 2025 – $
Current assetsCash and cash equivalents13,701,24711,371,834
Current assetsAccounts receivable, net (Note 4)3,239,6262,908,270
Current assetsInventory (Note 5)7,138,4007,081,295
Current assetsPrepaid expenses516,553563,912
Current assetsCurrent portion of notes receivable259,653253,403
Current assetsTotal current assets24,855,47922,178,714
Current assetsOther long-term assets300,000300,000
Current assetsWarrants asset (Note 6)2,912,1885,103,272
Current assetsOther Investments (Note 7)1,459,2031,358,860
Current assetsNotes receivable (Note 8)1,719,6941,683,757
Current assetsLease receivable94,02294,022
Current assetsProperty and equipment, net (Note 9)15,467,08814,055,552
Current assetsRight of use assets (Note 10)14,065,29513,414,406
Current assetsDeferred tax asset1,944,0781,522,760
Current assetsIntangible assets3,025,1933,025,193
Current assetsTOTAL ASSETS65,842,24062,736,536
Current liabilitiesAccounts payable and accrued liabilities2,731,6071,262,519
Current liabilitiesCurrent portion of operating lease liabilities965,115844,421
Current liabilitiesCurrent portion of finance lease liabilities158,477152,705
Current liabilitiesCurrent portion of long-term debt2,765,9002,576,228
Current liabilitiesCurrent portion of business acquisition consideration payable (Note 20)553,064455,844
Current liabilitiesDerivative liability70,664137,041
Current liabilitiesWarrant liabilities (Note 13.3)768,951
Current liabilitiesIncome tax payable286,980296,018
Current liabilitiesTotal current liabilities8,300,7585,724,776
Current liabilitiesOperating lease liabilities13,618,79813,010,805
Current liabilitiesFinance lease liabilities51,35967,782
Current liabilitiesLong-term debt9,916,22410,019,301
Current liabilitiesBusiness acquisition consideration payable (Note 20)1,485,8201,611,637
Current liabilitiesOther non-current liabilities9,227,3138,383,888
Current liabilitiesTotal liabilities42,600,27238,818,189

Cash Flow

(US$ in millions)

2026 – $2025 – $
Operating activitiesNet income (loss)-2,213,391742,870
Adjustments for non-cash items in net income (loss) and earnings impact of warrant liability reclassification:Depreciation of property and equipment91,162104,984
Adjustments for non-cash items in net income (loss) and earnings impact of warrant liability reclassification:Depreciation of property and equipment included in costs of finished cannabis inventory sold822,531315,216
Adjustments for non-cash items in net income (loss) and earnings impact of warrant liability reclassification:Lease costs included in costs of finished cannabis inventory sold199,41534,055
Adjustments for non-cash items in net income (loss) and earnings impact of warrant liability reclassification:Share-based compensation154,9941,435,910
Adjustments for non-cash items in net income (loss) and earnings impact of warrant liability reclassification:Interest and accretion expense549,980258,171
Adjustments for non-cash items in net income (loss) and earnings impact of warrant liability reclassification:Other income-41,501
Adjustments for non-cash items in net income (loss) and earnings impact of warrant liability reclassification:Interest income-42,187-35,937
Adjustments for non-cash items in net income (loss) and earnings impact of warrant liability reclassification:Unrealized (gain) loss on derivative liability-66,377-2,864,373
Adjustments for non-cash items in net income (loss) and earnings impact of warrant liability reclassification:Realized (gain) loss on derivative liability29,288
Adjustments for non-cash items in net income (loss) and earnings impact of warrant liability reclassification:Unrealized loss on warrant asset2,191,0841,172,492
Adjustments for non-cash items in net income (loss) and earnings impact of warrant liability reclassification:Unrealized gain on warrant liability-770,714
Adjustments for non-cash items in net income (loss) and earnings impact of warrant liability reclassification:Loss on equity investment in associate99,657153,734
Adjustments for non-cash items in net income (loss) and earnings impact of warrant liability reclassification:Deferred income taxes-421,318-63,418
Adjustments for non-cash items in net income (loss) and earnings impact of warrant liability reclassification:Changes in operating assets and liabilities (Note 19)1,939,688-2,246,071
Adjustments for non-cash items in net income (loss) and earnings impact of warrant liability reclassification:Net cash provided by (used in) operating activities2,534,524-1,004,580
Investing activitiesPurchase of property and equipment-2,517,414-241,532
Investing activitiesPayments of business acquisition consideration payable-157,199-43,290
Investing activitiesInvestment in Rogue EBC, LLC equity interest-200,000-49,000
Investing activitiesNet cash used in investing activities-2,874,613-333,822
Financing activitiesSale of non-controlling interest in GRMA, net of issuance costs2,985,000
Financing activitiesProceeds from exercise of stock options21,83916,038
Financing activitiesProceeds from long-term debt500,0007,250,155
Financing activitiesDistributions to non-controlling interests in subsidiaries-85,156
Financing activitiesDebt issuance costs-213,373
Financing activitiesRepayment of long-term debt-733,431-732,004
Financing activitiesPayment of interest on convertible debentures-75,529
Financing activitiesRepayment of finance lease-18,750
Financing activitiesNet cash provided by financing activities2,669,5026,245,287
Financing activitiesEffect of foreign exchange on cash and cash equivalents7,832
Financing activitiesChange in cash and cash equivalents2,329,4134,906,885
Financing activitiesCash and cash equivalents, beginning of period11,371,8344,917,708
Financing activitiesCash and cash equivalents, ending of period13,701,2479,832,425
Full release

Management is reiterating the financial framework introduced in April 2026 to assist investors in evaluating the Company's growth strategy and capital allocation discipline. The guidance and long-term objectives set out below reflect current expectations, assumptions, and management objectives as of the date of this release and are subject to the forward-looking statements disclosure included herein.

Growth Framework

Long-term (3-5 year) Targets and Guidance

2026 Guidance Assumptions:

2026 guidance excludes the start-up (pre-revenue) expenses in both Illinois and Minnesota of approximately $1.5 million to $2.0 million each. Illinois is expected to begin contributing revenue in Q4 2026 with approximately 5,000 square feet of flowering canopy initially online. Minnesota is expected to begin contributing revenue in the first quarter of 2027 with approximately 8,000 square feet of flowering canopy online. In New Jersey, the Company expects the current expansion to be substantially complete by Q4 2026, with ramp and sell-through reaching targeted levels by Q1 2027. As a result, the expansion is expected to contribute modestly to revenue and Adjusted EBITDA (non-GAAP) in 2026 and is more fully reflected in 2027 guidance. Overall, the Company anticipates consolidated gross margins of greater than 40% and corporate overhead expenses to increase by less than 10% in 2026.

2027 Guidance Assumptions:

2027 guidance assumes modest wholesale price normalization from 2026 levels in New Jersey and Illinois of approximately 10% and 5%, respectively. Minnesota is assumed to remain supply-constrained, supporting wholesale flower pricing above $2,500 per pound. In Oregon and Michigan, the guidance assumes no change in the current pricing environment, which management believes represents an appropriately conservative case for those markets. New Jersey assumes completion of the Phase II expansion in 2026, with 2027 reflecting a full year at expanded capacity. The Company currently plans to expand Illinois flowering canopy from 5,000 to 14,000 square feet and to expand Minnesota flowering canopy from 8,000 to approximately 16,000 square feet in mid-2027, utilizing existing capital and internally generated cash flow to fund the expansions.

Overall, the Company anticipates consolidated gross margins of greater than 42% and corporate overhead expenses to increase by less than

25% in 2027.

General Assumptions.

Guidance and long-term objectives exclude any potential changes in U.S. federal cannabis policy and do not assume M&A or additional distressed opportunities unless explicitly stated.

State-by-State Indoor Cultivation Flowering Capacity

(Bench Canopy)

On average, Grown Rogue anticipates producing approximately

800-900 lbs of flower annually per 1,000 square feet of flower canopy.

Conference Call and Webcast Information

Grown Rogue will host a conference call and webcast on Tuesday, May 12, 2026, at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time) to discuss its first quarter 2026 results and provide a corporate update

To further enhance investor disclosure, the Company will also post an updated Company Overview presentation to its website in advance of the call.

Conference Call Details

A telephone replay of the conference call will be available until May 19, 2026, by dialing (+1) 888 660 6345 and entering replay code 19264#. A transcript of the call will also be made available on Grown Rogue's Investor Relations website at https://www.grownrogue.com/investors.

For assistance, please contact: invest@grownrogue.com.

The contents of our investor relations website are not incorporated by reference into this press release or any report or document that

Grown Rogue files with the SEC or Canadian Securities Administrators ("CSA"), and any references to the websites are intended to be inactive textual references only.

About Grown Rogue

Grown Rogue International Inc. (CSE: GRIN | OTC: GRUSF) is a flower-forward cannabis company rooted in Oregon's Rogue Valley, a region known for its deep cannabis heritage and commitment to quality. With operations in Oregon, Michigan, and New Jersey - and expansion underway in Illinois and Minnesota - Grown Rogue specializes... (truncated) budtenders, and consumers alike. By blending craft values with disciplined execution, the Company has built a scalable, capital-efficient platform designed to thrive in competitive markets. The Company believes sustained excellence in cannabis flower production is the engine of the industry's supply chain - and its competitive advantage. For more information about Grown Rogue, please visit www.grownrogue.com.

The contents of our website are not incorporated by reference into this press release or any report or document that Grown Rogue files with the SEC or CSA, and any references to the websites are intended to be inactive textual references only.

Consolidated Statements of Income (Loss) and Comprehensive

Income (Loss) (Unaudited)

For the three months ended March 31, 2026 and 2025

(US$ in millions)

Consolidated Balance Sheets (Unaudited)

As of March 31, 2026 and December 31, 2025

(US$ in millions)

Consolidated Statements of Cash Flow (Unaudited)

For the three months ended March 31, 2026 and 2025

(US$ in millions)

Adjusted EBITDA Reconciliation Table (Unaudited)

Three months ended March 31, 2026

(US$ in millions)

Preliminary Segmented Adjusted EBITDA (Unaudited)

- Three months ended March 31, 2026

(US$ in millions)

Quarterly Adjusted EBITDA (Unaudited) - Trailing

5 quarters

(US$ in millions)

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This press release contains "forward looking information" and "forward-looking statements" within the meaning of applicable securities laws, including, without limitation, statements regarding: the Company's financial guidance and long-term targets; anticipated timing, capacity, ramp and revenue contributions in Illinois, Minnesota and New Jersey; future capital allocation; growth opportunities; pricing assumptions; working capital requirements; and the expected benefits of the Company's transition from IFRS to GAAP and consolidation of ABCO. Forward-looking statements are often identified by words such as "may," "would," "could,"

"should," "will," "intend," "plan," "anticipate," "believe," "estimate,"

"expect," "target," "guidance," or similar expressions.

Readers are cautioned to not place undue reliance on forward-looking information. Actual results and developments may differ materially from those contemplated by these statements. Although the Company believes that the expectations reflected in these statements are reasonable, forward-looking statements are based on management's current expectations, estimates, assumptions and projections as of the date of this release, including, without limitation, assumptions regarding market conditions, wholesale pricing, demand, construction timelines, regulatory approvals, capital availability, operating performance, and the timing of new market launches and expansion projects. Although the Company believes these assumptions are reasonable, forward-looking statements are inherently subject to risks and uncertainties, and undue reliance should not be placed on such statements.

Actual results may differ materially from those expressed or implied by forward-looking statements as a result of a number of known and unknown risks and uncertainties, including, without limitation: changes in general economic, business and political conditions; access to debt or equity capital on acceptable terms; adverse changes in the public perception of cannabis; decreases in prevailing prices for cannabis and cannabis products in the markets in which the Company operates; regulatory developments and the timing or availability of required approvals; the pace and cost of construction, commissioning and ramp activities; and the other risks described in the Company's public disclosure documents filed on SEDAR+ and www.sec.gov.

The Company does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law. Readers are cautioned that future-oriented financial information and financial outlooks contained in this release are provided for the purpose of describing management's current expectations and may not be appropriate for other purposes. The Company is indirectly involved in the manufacture, possession, use, sale and distribution of cannabis in the recreational cannabis marketplace in the United States through its indirect operating subsidiaries. Local state laws where its subsidiaries operate permit such activities; however, these activities are currently illegal under United States federal law. Additional information regarding this and other risks and uncertainties relating to the Company's business is disclosed in the Company's public disclosure documents filed on SEDAR+ and www.sec.gov.

Non-GAAP Financial Measures

This press release contains certain non-GAAP financial measures. These measures are presented as supplemental information and should not be considered a substitute for, or superior to, financial measures prepared in accordance with GAAP. Reconciliations of these non-GAAP measures to the most directly comparable GAAP measures are included in the financial schedules accompanying this release. Forward-looking non-GAAP guidance is provided on the basis described under "Guidance and Long-Term Growth Objectives."

SOURCE Grown Rogue International Inc.

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/May2026/12/c3762.html

%CIK: 0001463000

For further information:

General Inquiries and Investor Contact:

Obie Strickler, Chief Executive Officer, obie@grownrogue.com; Investor Relations: invest@grownrogue.com, (458) 226-2662

CO: Grown Rogue International Inc.

CNW 16:05e 12-MAY-26

From SEC EDGAR. Analysis by Pear Digitals from the filing alone. Not investment advice. · Grown Rogue International earnings · Latest earnings · Markdown

Screener

Plans

Premium and Pro coming soon.

Log in

New here?

Join the waitlist

Pear FMV opens to everyone soon. We'll email you when it does.